Carole Delauney has been Senior Director Business Development since September 2020 at Swissfillon, acquired by ten23 health in October 2021. Carole handled similar roles at small and large CDMOs based in Europe and US since she started her career in 2003 and is focusing on sterile fill finish since 2007. She holds a five-year degree in Biochemistry from the University of Montpellier (France).